{"id":"https://openalex.org/W2016019669","doi":"https://doi.org/10.1016/j.bbmt.2012.11.044","title":"Nicord\u00ae Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation","display_name":"Nicord\u00ae Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation","publication_year":2013,"publication_date":"2013-01-23","ids":{"openalex":"https://openalex.org/W2016019669","doi":"https://doi.org/10.1016/j.bbmt.2012.11.044","mag":"2016019669"},"language":"en","primary_location":{"id":"doi:10.1016/j.bbmt.2012.11.044","doi":"https://doi.org/10.1016/j.bbmt.2012.11.044","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2012.11.044","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.bbmt.2012.11.044","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018922885","display_name":"Mitchell E. Horwitz","orcid":"https://orcid.org/0000-0001-9863-8464","observed_orcids":["https://orcid.org/0000-0001-9863-8464"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mitchell E. Horwitz","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013177563","display_name":"Patrick J. Stiff","orcid":"https://orcid.org/0000-0001-8265-9340","observed_orcids":["https://orcid.org/0000-0001-8265-9340"]},"institutions":[{"id":"https://openalex.org/I1304196042","display_name":"Loyola University Medical Center","ror":"https://ror.org/05xcyt367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304196042","https://openalex.org/I1304269903"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick J. Stiff","raw_affiliation_strings":["Loyola Univ Medical Center, Maywood, IL","Loyola University medical Center, Maywood, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Loyola Univ Medical Center, Maywood, IL","institution_ids":["https://openalex.org/I1304196042"]},{"raw_affiliation_string":"Loyola University medical Center, Maywood, IL","institution_ids":["https://openalex.org/I1304196042"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034651124","display_name":"Nelson Jen An Chao","orcid":"https://orcid.org/0000-0001-6725-7220","observed_orcids":["https://orcid.org/0000-0001-6725-7220"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nelson J. Chao","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061865992","display_name":"David Alan Rizzieri","orcid":"https://orcid.org/0000-0001-9886-5771","observed_orcids":["https://orcid.org/0000-0001-9886-5771"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Rizzieri","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112929069","display_name":"Gwynn Douglas Long","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gwynn Long","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037247107","display_name":"Keith M. Sullivan","orcid":"https://orcid.org/0000-0002-1379-9216","observed_orcids":["https://orcid.org/0000-0002-1379-9216"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Sullivan","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033550793","display_name":"Cristina Gasparetto","orcid":"https://orcid.org/0000-0003-1513-5605","observed_orcids":["https://orcid.org/0000-0003-1513-5605"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristina Gasparetto","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083678047","display_name":"John P. Chute","orcid":"https://orcid.org/0000-0002-8841-0527","observed_orcids":["https://orcid.org/0000-0002-8841-0527"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Chute","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090348866","display_name":"Ashley Morris","orcid":"https://orcid.org/0009-0003-6921-6539","observed_orcids":["https://orcid.org/0009-0003-6921-6539"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley Morris","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114249322","display_name":"Carolyn S. McDonald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn McDonald","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109930691","display_name":"Steve Wease","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115849","display_name":"Emmes (United States)","ror":"https://ror.org/027fvqp63","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115849"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Wease","raw_affiliation_strings":["EMMES Corporation, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMMES Corporation, Rockville, MD","institution_ids":["https://openalex.org/I4210115849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113550483","display_name":"David S. Snyder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138946","display_name":"Gamida Cell (Israel)","ror":"https://ror.org/03samhn24","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210138946"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"David Snyder","raw_affiliation_strings":["Gamida Cell Ltd., Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gamida Cell Ltd., Jerusalem, Israel","institution_ids":["https://openalex.org/I4210138946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071980209","display_name":"Einat Galamidi-Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138946","display_name":"Gamida Cell (Israel)","ror":"https://ror.org/03samhn24","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210138946"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Einat Galamidi-Cohen","raw_affiliation_strings":["Gamida Cell Ltd., Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gamida Cell Ltd., Jerusalem, Israel","institution_ids":["https://openalex.org/I4210138946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075688675","display_name":"Hadas Shoham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138946","display_name":"Gamida Cell (Israel)","ror":"https://ror.org/03samhn24","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210138946"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Hadas Shoham","raw_affiliation_strings":["Gamida Cell Ltd., Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gamida Cell Ltd., Jerusalem, Israel","institution_ids":["https://openalex.org/I4210138946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015744004","display_name":"Efrat Landau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138946","display_name":"Gamida Cell (Israel)","ror":"https://ror.org/03samhn24","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210138946"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Efrat Landau","raw_affiliation_strings":["Gamida Cell Ltd., Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gamida Cell Ltd., Jerusalem, Israel","institution_ids":["https://openalex.org/I4210138946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011815694","display_name":"Etty Friend","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138946","display_name":"Gamida Cell (Israel)","ror":"https://ror.org/03samhn24","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210138946"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Etty Friend","raw_affiliation_strings":["Gamida Cell Ltd., Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gamida Cell Ltd., Jerusalem, Israel","institution_ids":["https://openalex.org/I4210138946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060384074","display_name":"Joanne Kurtzberg","orcid":"https://orcid.org/0000-0002-3370-0703","observed_orcids":["https://orcid.org/0000-0002-3370-0703"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne Kurtzberg","raw_affiliation_strings":["Pediatric Blood and Marrow Transplant Program, Duke University Medical Center, Durham, NC","Pediatric Blood and Marrow Transplant Program, Duke University Medical Center, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Blood and Marrow Transplant Program, Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Pediatric Blood and Marrow Transplant Program, Duke University Medical Center, Durham, NC;","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110031014","display_name":"Tony Peled","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138946","display_name":"Gamida Cell (Israel)","ror":"https://ror.org/03samhn24","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210138946"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Tony Peled","raw_affiliation_strings":["Gamida Cell Ltd., Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gamida Cell Ltd., Jerusalem, Israel","institution_ids":["https://openalex.org/I4210138946"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.6406,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.72007035,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"19","issue":"2","first_page":"S118","last_page":"S118"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10176","display_name":"Mesenchymal stem cell research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cord-blood-transplantation","display_name":"cord blood transplantation","score":0.8809999823570251},{"id":"https://openalex.org/keywords/myeloablative-conditioning","display_name":"myeloablative conditioning","score":0.7620000243186951},{"id":"https://openalex.org/keywords/t-cell-engraftment","display_name":"T cell engraftment","score":0.8080000281333923},{"id":"https://openalex.org/keywords/myeloid-engraftment","display_name":"myeloid engraftment","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cd133-cells","display_name":"CD133+ cells","score":0.7049999833106995},{"id":"https://openalex.org/keywords/nicotinamide","display_name":"nicotinamide","score":0.8939999938011169},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.8460000157356262},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9160000085830688}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9060923457145691},{"id":"https://openalex.org/C2776955114","wikidata":"https://www.wikidata.org/wiki/Q172563","display_name":"Umbilical cord","level":2,"score":0.8102242946624756},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.6940052509307861},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.6579821705818176},{"id":"https://openalex.org/C2780914630","wikidata":"https://www.wikidata.org/wiki/Q914952","display_name":"Cord blood","level":2,"score":0.5802656412124634},{"id":"https://openalex.org/C2908824208","wikidata":"https://www.wikidata.org/wiki/Q914952","display_name":"Umbilical Cord Blood Transplantation","level":4,"score":0.5493027567863464},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4991950988769531},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.49715521931648254},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.38590314984321594},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3738579750061035},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.2955739200115204},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20547163486480713},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07504189014434814},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.06560119986534119}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.bbmt.2012.11.044","doi":"https://doi.org/10.1016/j.bbmt.2012.11.044","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2012.11.044","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.bbmt.2012.11.044","doi":"https://doi.org/10.1016/j.bbmt.2012.11.044","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2012.11.044","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.5099999904632568,"display_name":"Zero hunger","id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2380255730","https://openalex.org/W3092665883","https://openalex.org/W2424415759","https://openalex.org/W3114614760","https://openalex.org/W1991560579","https://openalex.org/W3182322479","https://openalex.org/W2372223699","https://openalex.org/W2946104632","https://openalex.org/W2809830649","https://openalex.org/W2978934798"],"abstract_inverted_index":{"Human":[0],"transplantation":[1,26],"of":[2,22,46],"expanded":[3,32,48,58],"HPCs":[4,56],"resulting":[5],"in":[6,62],"durable,":[7],"robust":[8],"donor":[9],"myeloid":[10],"and":[11,50],"T-cell":[12,54],"engraftment":[13],"has":[14,38],"yet":[15],"to":[16],"be":[17],"reported.":[18],"A":[19],"pilot":[20],"study":[21],"myeloablative":[23],"dual":[24],"UCB":[25,29,43],"where":[27],"one":[28],"unit":[30],"is":[31],"ex":[33],"vivo":[34],"using":[35],"NiCord":[36,42],"technology":[37],"completed":[39],"accrual.":[40],"The":[41],"graft":[44],"consisted":[45],"an":[47,51],"CD133+":[49],"unexpanded":[52],"CD133-":[53],"fraction.":[55],"were":[57,72],"for":[59],"21":[60],"days":[61],"media":[63],"containing":[64],"cytokines":[65],"supplemented":[66],"with":[67,74],"nicotinamide":[68],"(NAM).":[69],"All":[70],"patients":[71],"conditioned":[73],"TBI":[75],"(1350cGy),":[76],"fludarabine":[77],"160mg/m2":[78],"\u00b1cyclophosphamide":[79],"120mg/kg":[80],"(n=2).":[81]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":3}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}